Suboptimal adherence to hormone therapy was associated with higher medical costs, but optimal adherence was not associated with total cost savings across a 4-year period.
Z. Kevin Lu, PhD
Advertisement
Articles by Z. Kevin Lu, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
CagriSema Outperforms Semaglutide in Lowering HbA1C, Reducing Weight Across REIMAGINE Trials
2
Drug Shortages Are Declining, But Persistent Supply Chain Vulnerabilities Continue to Threaten Access
3
The Peptide Surge: Counseling Guidance on GLP-1s, Compounded Therapies, and What Patients Want to Know
4
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
5